8-K: Danimer Scientific Faces Debt Acceleration, Negotiates Forbearance Agreement

Danimer Scientific received notices of default and acceleration on its Senior Secured Note and Term Loan, subsequently entering into a forbearance agreement to temporarily prevent enforcement actions.

Summary

• Danimer Scientific received a notice of default and acceleration on its Senior Secured Note on February 5, 2025.
• The company entered into a forbearance agreement with the Payees of the Senior Secured Note, preventing enforcement of remedies until the earliest of March 1, 2025, another event of default, or a breach of the forbearance agreement.
• The interest rate on the Senior Secured Note increased from 15.0% to 17.0% per annum due to the events of default.
• The company paid all unpaid costs and expenses of the Payees in exchange for the forbearance agreement.
• As of the notice of acceleration, the aggregate amount owed under the Senior Secured Note was approximately $14.9 million.
• Danimer Scientific also received a notice of acceleration on its Term Loan due to the acceleration of the Senior Secured Note.
• The lenders under the Term Loan have agreed to a standstill period of 180 days, during which they generally may not enforce payment obligations.
• As of the receipt of the Term Loan Notice of Acceleration, the aggregate amount owed under the Term Loan, including accrued interest, was approximately $133.5 million.

Sentiment

Score: 2

Explanation: The announcement of debt acceleration and default, despite the forbearance agreement, indicates a highly negative situation for the company's financial health and investor confidence.

Positives

• The forbearance agreement provides temporary relief from immediate enforcement actions related to the Senior Secured Note.
• The standstill period from the Term Loan lenders offers a window of 180 days to address the financial issues without immediate enforcement.
• The company has addressed the immediate concern of unpaid costs and expenses of the Payees by paying them in full.

Negatives

• The acceleration of both the Senior Secured Note and the Term Loan indicates significant financial distress.
• The increased interest rate on the Senior Secured Note from 15.0% to 17.0% will increase the company's debt servicing costs.
• The company is in breach of its debt obligations, which could negatively impact its reputation and future access to capital.

Risks

• Failure to resolve the defaults before the expiration of the forbearance agreement or the occurrence of another event of default could lead to enforcement actions by the Payees.
• The company's ability to continue as a going concern is uncertain given the significant debt obligations and the acceleration notices.
• The standstill period on the Term Loan is temporary, and enforcement actions could resume after 180 days if the defaults are not resolved.
• The cross-default provisions between the Senior Secured Note and the Term Loan create additional financial risk.

Future Outlook

The company does not anticipate any further action to be taken by the lenders under the Term Loan that would materially impact the Company during the Standstill Period.

Industry Context

This announcement highlights the challenges faced by companies in the bioplastics industry, particularly those with significant debt burdens. It is important to monitor how Danimer Scientific's situation compares to its peers and the broader market trends in sustainable materials.

Comparison to Industry Standards

• It's difficult to compare Danimer Scientific's situation directly to industry standards without more specific financial data from comparable companies.
• However, companies like Novamont and Corbion, which are also involved in bioplastics, have different financial structures and may not be directly comparable.
• The debt levels and default events should be benchmarked against other companies in the materials science and sustainable packaging sectors to assess the severity of Danimer's financial distress.

Stakeholder Impact

• Shareholders face significant risk of loss due to the company's financial distress.
• Employees may be concerned about job security given the company's uncertain future.
• Suppliers and customers may be hesitant to engage in long-term contracts with the company due to its financial instability.
• Creditors face the risk of not being fully repaid on their outstanding loans.

Next Steps

• Danimer Scientific needs to negotiate a long-term solution with its lenders to address the outstanding debt and avoid further enforcement actions.
• The company must comply with the terms of the forbearance agreement to prevent its termination.
• Danimer Scientific needs to improve its financial performance to meet its debt obligations and restore investor confidence.

Key Dates